ASSOCIATION BETWEEN SERUM URIC ACID AND METABOLIC SYNDROME
Keywords:Uric acid, Metabolic syndrome, Antioxidants
Objective: Metabolic syndrome is a cluster of disease condition characterized by truncal obesity, hypertriglyceridemia, elevated blood pressure, and insulin resistance. An excessive circulating uric acid (UA) level even within normal range is always comorbid with metabolic syndrome and its components. The aim of the current study was to investigate the association between metabolic syndrome and serum UA level.
Methods: A total of 60 subjects were divided into two groups of healthy (30 individuals) and metabolic syndrome patients (30 individuals) from dental outpatient department of Saveetha Dental College and Hospitals. 5 ml of fasting venous blood was collected in the plain collection tubes and centrifuged, and then serum was separated. Then, the serum was used to analyze the fasting blood glucose, serum triglycerides (TGLs), and serum UA by GOD-POD, enzymatic colorimetric, and uricase method, respectively. A statistical analysis was performed using Student's t-test. p<0.05 was considered to be statistically significant.
Result: Mean body mass index (BMI), fasting blood sugar (FBS), TGL, and UA level of control group were 23.36Â±1.81, 84.45Â±13.1, 110.9Â±22.6, and 3.48Â±1.21 respectively. Mean BMI, FBS, TGL, and UA level of study group were 35.24Â±3.04, 122.85Â±23.3, 212.1Â±39.6 and 9.08Â±2.63 respectively. There is a significant difference between these two groups with p<0.0001.
Conclusion: This study showed that those individuals with metabolic syndrome have higher UA level that indicates hyperuricemia which is a significant predictor of metabolic syndrome.
Nejatinamini S, Ataie-Jafari A, Qorbani M, Nikoohemat S, Kelishadi R, Asayesh H, et al. Association between serum uric acid level and metabolic syndrome components. J Diabetes Metab Disord 2015;14:70.
Guru EP, Savitha G. Prevalence of coronary atherosclerotic heart disease in metabolic syndrome patients. J Pharm Sci Res 2015;7 Suppl 9:724-6.
Mounoka S, Savitha G. Association of periodontal diseases and metabolic syndrome. Res J Pharm Tech 2015;8 Suppl 8:994-6.
Nerkar D, Mukherjee A, Mehta BK, Banerjee S. Metabolic syndrome associated complications. Int J Pharm Pharm Sci 2015;7 Suppl 7:22-5.
Yuan H, Yu C, Li X, Sun L, Zhu X, Zhao C, et al. Serum uric acid levels and risk of metabolic syndrome: A Dose-response meta-analysis of prospective studies. J Clin Endocrinol Metab 2015;100:4198-207.
Cirillo P, Sato W, Reungjui S, Heinig M, Gersch M, Sautin Y, et al. Uric acid, the metabolic syndrome, and renal disease. J Am Soc Nephrol 2006;17:S165-8.
Ridi RE, Tallima H. Physiological functions and pathological potential of uric acid: A review. J Adv Res 2017;8 Suppl 5:487-93.
Beckar BF. Towards the physiological function of uric acid. Free Radic Biol Med 1993;14 Suppl 6:615-631.
Glantzounik GK, Tsimoyiannis EC, Kappas AM, Galaris DA. Uric acid and oxidative stress. Curr Pharm Des 2005;11 Suppl 32:4145-51.
Alexander SO, Thorens B. Uric acid transport and disease. J Clin Invest 2010;120 Suppl 6:1791-9.
Fabbrini E, Serafini M, Colic Baric I, Hazen SL, Klein S. Effect of plasma uric acid on antioxidant capacity, oxidative stress, and insulin sensitivity in obese subjects. Diabetes 2014;63:976-81.
Ames BN, Cathcart R, Schwiers E, Hochstein P. Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: A hypothesis. Proc Natl Acad Sci U S A 1981;78:6858-62.
Kwak HK, Yoon S. Relation of serum total antioxidant status with metabolic risk factors in Korean adults. Nutr Res Pract 2007;1:335-40.
Najarzadeh A, Mozaffari-Khosravi H, Mahdavi M, Fallahzadeh H, Zavar-Reza J, Shahmoradi H. Antioxidant status in patients with metabolic syndrome as measured by the stable free radical diphenylpicrylhydrazyl Assay. Iran J Diabetes Obesity 2012;40:161-6.
Silva HA, Carraro JC, Bressan J, Hermsdorff HH. Relation between uric acid and metabolic syndrome. Einstein 2015;13 Suppl 2:202-8.
Usama AA, El Din S, Salem MM, Abdulazim DO. Uricacid in the pathogenesis of metabolic, renal and cardiovascular diseases: A review. J Adv Res 2017;8 Suppl 5:537-48.
Chen LY, Zhu WH, Chen ZW, Dai HL, Ren JJ, Chen JH, et al. Relationship between hyperuricemia and metabolic syndrome. J Zhejiang Univ Sci B 2007;8:593-8.
Lee D, Oh WJ, Yi MK, Han SW, Yun JW, Han SH. The relevance of hyperuricemia and metabolic syndrome and the effect of blood Lead level on uricacid concentration in steelmaking workers. Ann Occup Environ Med 2013;25:27.
How to Cite
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.